Transforming Preventive Healthcare Through Innovation
From concept to global commercialization, Bioflex USA Life Technologies identifies, develops, and advances innovative medical technologies through clinical validation, regulatory strategy, manufacturing, and international market expansion.
We build a portfolio of high-impact medical technologies — connecting innovation to healthcare markets worldwide and ensuring life-changing solutions reach the patients who need them most.
A Global Platform for Medical Technology Commercialization
Many promising healthcare innovations never reach the patients they were designed to serve.
- Some lack regulatory guidance and a clear pathway to market.
- Some lack commercialization strategy, manufacturing support, or capital.
- Others lack market access, distribution networks, or global expansion capabilities.
Bioflex USA Life Technologies was founded to bridge these gaps. We identify unmet clinical needs, develop and acquire innovative medical technologies, and support every stage from validation to global commercialization — connecting innovation with healthcare markets worldwide.
From Concept to Global Commercialization
Bioflex provides a proven, structured pathway that guides healthcare innovations from proof of concept through clinical validation, regulatory strategy, manufacturing readiness, commercialization, and global market expansion — one platform, global reach, life-changing solutions.
Identifying unmet clinical needs and breakthrough technologies with transformative potential.
Rigorous scientific evaluation ensuring efficacy, safety, and evidence-based clinical performance.
Navigating FDA and international regulatory pathways to market authorization.
Scaling production capabilities to meet global quality and demand standards.
Market entry strategy, pricing, positioning, and go-to-market execution.
Cross-border licensing, distribution partnerships, and global market access.
Building alliances that accelerate global adoption and sustainable healthcare impact.
Identifying unmet clinical needs and breakthrough technologies with transformative potential.
Rigorous scientific evaluation ensuring efficacy, safety, and evidence-based clinical performance.
Navigating FDA and international regulatory pathways to market authorization.
Scaling production capabilities to meet global quality and demand standards.
Market entry strategy, pricing, positioning, and go-to-market execution.
Cross-border licensing, distribution partnerships, and global market access.
Building alliances that accelerate global adoption and sustainable healthcare impact.
Advancing Technologies That Improve Lives
Every technology we support must meaningfully improve healthcare delivery, patient experience, and clinical outcomes.
Prevention
Prioritizing technologies that help prevent disease before onset.
Early Detection
Supporting innovations that identify conditions at their earliest, most treatable stages.
Patient Experience
Advancing solutions designed around comfort, dignity, and patient-centered care.
Clinical Performance
Ensuring technologies meet rigorous clinical standards for safety and efficacy.
Operational Efficiency
Helping healthcare systems deliver better outcomes at reduced cost.
Population Health
Scaling solutions that benefit entire communities and patient populations.
Healthcare Accessibility
Making transformative technologies available across diverse global markets.
Bioflex prioritizes innovations that support prevention, early detection, patient experience, and improved healthcare outcomes — across every stage of the technology lifecycle.
MammoGRIP® is Bioflex's flagship commercialization success — a medical device developed to address a critical challenge in breast imaging. MammoGRIP® has progressed from innovative concept to clinically studied, internationally commercialized medical technology.
Today, MammoGRIP® demonstrates the Bioflex platform in action: thoughtful innovation, clinical validation, regulatory planning, and global commercialization strategy combining to create meaningful healthcare impact.
Visit MammoGRIP®
Building Global Pathways
MammoGRIP® commercialization is actively developed across five global territories — each representing a strategic pathway toward broader patient access and healthcare impact.
Headquarters & Primary Market
South American Operations
Portugal & Spain — EU Entry Point
Continental Expansion
Development Stage
Partners in Healthcare Innovation
Our success depends on collaboration. Bioflex works with organizations that share our commitment to advancing healthcare through responsible innovation, global accessibility, and meaningful patient impact.
Inventors
Visionary individuals with breakthrough healthcare concepts.
Medical Technology Companies
Organizations developing clinical tools, diagnostics, and medical devices.
Healthcare Systems
Hospitals, clinics, and imaging centers worldwide.
Distributors
Regional and global distribution networks.
Manufacturers
Contract and OEM manufacturing partners.
Investors
Capital partners aligned with healthcare impact and innovation.
Strategic Partners
Organizations sharing our mission of global healthcare accessibility.
"Commercialization is not merely about bringing products to market — it is about ensuring meaningful innovations reach the patients who need them."
One Platform. Global Reach. Life-Changing Solutions.
We believe commercialization is not merely about bringing products to market.
It is about ensuring that meaningful innovations reach the patients, providers, and healthcare systems capable of benefiting from them.
Our goal is to build sustainable pathways that transform innovation into measurable, lasting healthcare impact.
Mission-Driven
We are guided by a singular purpose: ensuring innovations that can improve lives actually reach the patients who need them.
Globally Oriented
We build international pathways that connect medical technologies to markets across multiple continents and regulatory environments.
Evidence-Based
Every technology we champion is grounded in rigorous scientific validation and clear clinical evidence.
Patient-Centered
Our ultimate measure of success is meaningful improvement in patient experience and healthcare outcomes.
A Message From Our Founder
Throughout my career as a physician, I have witnessed extraordinary innovations with the potential to improve lives, yet many never reach the patients they were designed to serve.
Some fail because they lack funding. Others because they lack regulatory guidance, commercialization strategy, manufacturing support, or access to global markets.
At Bioflex USA Life Technologies, we believe innovation alone is not enough. Innovation must be validated, developed, commercialized, and delivered.
Our mission is to identify and foster medical technologies that prioritize prevention, early detection, patient experience, and improved healthcare outcomes. We work to bridge the gap between promising ideas and real-world impact by creating pathways that transform innovation into accessible healthcare solutions.
MammoGRIP® represents one example of this philosophy in action. What began as a simple concept evolved into a clinically studied, internationally commercialized medical technology designed to improve the mammography experience for women worldwide.
But our vision extends beyond any single product. We believe that meaningful healthcare innovation can come from anywhere, and that patients everywhere deserve access to technologies capable of improving their lives.
Thank you to our partners, investors, healthcare professionals, distributors, manufacturers, researchers, and stakeholders who share this mission.
Commercial Leadership
Jeff Cook
Director of Sales & Commercial Operations
Jeff Cook is a healthcare executive with more than three decades of leadership experience spanning the biopharmaceutical, medical device, and specialty healthcare industries. Throughout his career, he has contributed to the successful commercialization and launch of more than twelve innovative therapies and medical technologies while leading initiatives in commercialization, market access, managed markets, trade and distribution, reimbursement strategy, contracting, and strategic partnerships.
Prior to joining Bioflex USA Life Technologies, Jeff held leadership roles with Genentech, Johnson & Johnson (Cordis and Centocor), CellzDirect, Acorda Therapeutics, ONY Inc., and AccessBiomedical. His experience includes building high-performing commercial organizations, developing national account strategies, negotiating health system and GPO partnerships, launching new technologies, and advising executive leadership teams on commercialization and sustainable growth.
For more than a decade, Jeff has focused on helping emerging life science and healthcare companies successfully transition from product development to commercial execution. His expertise spans specialty pharmaceuticals, physician practice development, infusion services, regenerative medicine, women's health, market access, and healthcare innovation, with a strong emphasis on building strategic partnerships that expand patient access and accelerate responsible commercialization.
At Bioflex USA Life Technologies, Jeff leads commercial strategy and sales operations, supporting the global commercialization of innovative healthcare technologies while helping establish scalable partnerships that advance the company's long-term mission.
Let's Advance Healthcare Together
Whether you are an innovator, investor, manufacturer, healthcare organization, distributor, or strategic partner — Bioflex welcomes opportunities to collaborate, license, invest, distribute, and expand the reach of meaningful medical technologies globally.